Updated Drug Shortage Information for September 9, 2026

New Shortages

September 09, 2026

• Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous Injection (Discontinuation)

Shortage Updates

September 09, 2026

• Bupivacaine Hydrochloride Injection (Currently in Shortage)
• Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection (Currently in Shortage)
• Carboplatin Injection (Currently in Shortage)
• Epinephrine Bitartrate, Lidocaine Hydrochloride Injection (Currently in Shortage)
• Fentanyl Citrate Injection (Currently in Shortage)
• Furosemide Injection (Currently in Shortage)
• Heparin Sodium Injection (Currently in Shortage)
• Hydromorphone Hydrochloride Injection (Currently in Shortage)
• Ketorolac Tromethamine Injection (Currently in Shortage)
• Lidocaine Hydrochloride Injection (Currently in Shortage)
• Lorazepam Injection (Currently in Shortage)
• Meperidine Hydrochloride Injection (Currently in Shortage)
• Midazolam Hydrochloride Injection (Currently in Shortage)
• Morphine Sulfate Injection (Currently in Shortage)
• Sodium Bicarbonate Injection (Currently in Shortage)
• Sterile Water Injection (Currently in Shortage)
• Sufentanil Citrate Injection (Currently in Shortage)